Nucleus Formulation Private Limited - Company Profile

It is a pharma private limited company based in Chhatral, Gujarat, India, established in 2009.
2009 Chhatral, Gujarat, India Active
Last Updated:
Access Report
About Nucleus Formulation Private Limited

Nucleus Formulation Private Limited, a active private limited company, was established on 13 July 2009 in Chhatral, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GJ2009PTC057517. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Employing 13 professional, Its leadership includes Jitendra Lavjibhai Patel (Director), Dipesh Jyotindrakumar Thakar (Director). Past directors included Sureshbhai Kadavabhai Patel, Jayesh Sharadchandra Pandya. It holds ₹2.57 Cr open charges and ₹5.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 3484 Ph-4 Gidc Chhatral, Tal Kalol, Chhatral, Gujarat, 382729.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239GJ2009PTC057517

  • Registration Number

    057517

  • Incorporation Date

    13 July 2009

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.57 Cr
  • Satisfied Charges ₹ 5.83 Cr
  • Revenue Growth **** -25.66%
  • Profit Growth **** -39.83%
  • Ebitda **** -47.29%
  • Net Worth 8.06%
  • Total Assets **** 10.24%
Company report

Nucleus Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nucleus Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nucleus Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Lavjibhai Patel Director 13 Jul 2009 Current
Dipesh Jyotindrakumar Thakar Director 13 Jul 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Oct 2015 Past
Pramod Abcsdd Director 20 Mar 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nucleus Formulation.

Nucleus Formulation Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 25.66% decrease. The company also saw a substantial fall in profitability, with a 39.83% decrease in profit. The company's net worth moved up by a moderate rise of 8.06%.

Nucleus Formulation revenue growth over time
Nucleus Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -25.66%
*******
*******
*******
*******
Revenue from Operations
*******
 -26.00%
*******
*******
*******
*******
Total Assets
*******
 10.24%
*******
*******
*******
*******
Profit or Loss
*******
 -39.83%
*******
*******
*******
*******
Net Worth
*******
 8.06%
*******
*******
*******
*******
EBITDA
*******
 -47.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nucleus Formulation?

Unlock access to Nucleus Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹25,660,000.00

Satisfied Charges

₹58,300,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
  • Sidbi : 0.53 Cr
  • Hdfc Bank Limited : 0.04 Cr
Latest Charge Details
Date Lender Amount Status
28 Jul 2023 Sidbi ₹5.26 M Open
06 Jun 2023 Others ₹2.00 Cr Open
24 Jun 2021 Hdfc Bank Limited ₹0.40 M Open
11 Apr 2019 Others ₹2.50 Cr Satisfied
09 Oct 2014 Hdfc Bank Limited ₹1.36 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nucleus Formulation?

Nucleus Formulation has a workforce of 13 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nucleus Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nucleus Formulation
Recent Activity within the Organization
  • Annual General Meeting

    Nucleus Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Nucleus Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 5.26 M with Charge ID 100755911 was registered on 28 Jul 2023. was documented.

  • Charges

    The activity A charge registered on 11 Apr 2019 via Charge ID 100259131 with Others was fully satisfied on 30 Jun 2023. was completed.

  • Charges

    A charge with Others amounted to Rs. 20.00 M with Charge ID 100746083 was registered on 06 Jun 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.40 M with Charge ID 100465568 was registered on 24 Jun 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nucleus Formulation Private Limited?

The CIN of Nucleus Formulation Private Limited is U24239GJ2009PTC057517.

Where is Nucleus Formulation Private Limited headquartered?

Nucleus Formulation Private Limited is headquartered at Plot No 3484 Ph-4 Gidc Chhatral, Tal Kalol, Chhatral, Gujarat, 382729.

When was Nucleus Formulation Private Limited incorporated?

Nucleus Formulation Private Limited was incorporated on 13 July 2009.

Who are the current directors of Nucleus Formulation Private Limited?

The current directors of Nucleus Formulation Private Limited are

What is the primary industry of Nucleus Formulation Private Limited?

The primary industry of Nucleus Formulation Private Limited is Manufacturing.

Is Nucleus Formulation Private Limited a listed company?

Nucleus Formulation Private Limited is unlisted.

What is the capital structure of Nucleus Formulation Private Limited?

The authorized capital of Nucleus Formulation Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Nucleus Formulation Private Limited?

The compliance status of Nucleus Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available